Bayesian Capital Management, LP Insmed Inc Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $692,412 - $938,393	29,565 New	29,565 $916,000
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $27,168 - $37,040	-1,600 Reduced 8.75%	16,696 $333,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $382,020 - $516,130	18,296 New	18,296 $394,000
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $307,260 - $462,780	-18,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $367,560 - $506,340	18,000 New	18,000 $423,000
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $162,265 - $338,330	-11,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $156,745 - $390,769	11,500 New	11,500 $184,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.